MHRA approves Nucala for eosinophilic COPD in adults on triple therapy - PharmaTimes New biologic option shown to reduce exacerbations and extend time to first flare

#MHRA #GSK #Nucala #mepolizumab #eosinophilicCOPD #tripletherapy #biologics #UK #addonmaintenancetreatment #uncontrolledCOPD #MATINEE #METREX #KingsCentreforLungHealth #RespiratoryMedicine #COPDpatients #NICE #emergencyhospitaladmissions #COPDExacerbations #SMC #reimbursement
zurl.co/ro5Og

China clears GSK's Nucala for COPD GSK has unlocked a big new market for Nucala for COPD - China - which accounts for around a quarter of the global patient population.

#GSK has claimed an important new approval for #Nucala in chronic obstructive pulmonary disease (#COPD), in #China, which is estimated to account for around a quarter of the #globalpatientpopulation.

pharmaphorum.com/news/china-c...

GSK closes on approval of asthma hope depemokimab GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.

#GSK #depemokimab #severeasthma #Exdensur #CRSwNP #respiratory #immunology #inflammation #Nucala #mepolizumab #COPD #rarediseases #SerumLifeScienceEurope #Anktiva #NMIBC #SFLPharma #Aumseqa #NSCLC #Cytokinetics #Myqorzo #hypertrophiccardiomyopathy #Moderna #Mnexspike #COVID19vaccine
zurl.co/l8WfN

What is Nucala (mepolizumab) used for and how is it given? Official answer: Nucala (mepolizumab) is a biologic therapy used for the treatment of severe eosinophilic asthma, eosinophilic...

#Nucala (mepolizumab) treats severe eosinophilic asthma, nasal polyps, EGPA, and HES through monthly SC injections. This IL-5 antagonist controls eosinophil levels, reducing exacerbations and steroid dependence. Available as an autoinjector or syringe for ages 6+.

Nucala Patient Tips: 7 things you should know Easy-to-read patient tips for Nucala covering how it works, benefits, risks, and best practices.

#Nucala: Biologic blocking IL-5 to reduce eosinophils. Treats severe eosinophilic asthma, eosinophilic COPD, EGPA, hypereosinophilic syndrome, chronic rhinosinusitis with nasal polyps. Side effects include headaches, injection site reactions, risk of herpes zoster.

A flatlay of injection supplies including alcohol wipes, bandages, a prefilled syringe, and three autoinjectors.

Happy monthly human pincushion day to me. #hypereosinophilicsyndrome #Nucala

Respiratory Weekly News – May 9th 2025 Lung & Respiratory Health Breakthroughs: Nucala COPD Data, Breztri Asthma Milestones, Vapendavir Antiviral Results & More In this week’s Lung […] The post Respiratory Weekly News – May 9th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Respiratory Weekly News – May 9th 2025 #News #ChronicBronchitis #nucala #vapendavir Comment below!

🎉A decade of Nucala🎉 - and an inspiring symposium to match!

Grateful to be part of the amazing speaker lineup and the ongoing conversation around eosinophilic airway disease and its future.

Cheers to 10 years of progress!

#Nucala #Mepolizumab #Immunology #ImmunoSky #MedSky #CRS #Eosinophil

Respiratory Weekly News – May 9th 2025 Lung & Respiratory Health Breakthroughs: Nucala COPD Data, Breztri Asthma Milestones, Vapendavir Antiviral Results & More In this week’s Lung […] The post Respiratory Weekly News – May 9th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Respiratory Weekly News – May 9th 2025 #News #ChronicBronchitis #nucala #vapendavir Comment below!

Respiratory Weekly News – May 9th 2025 Lung & Respiratory Health Breakthroughs: Nucala COPD Data, Breztri Asthma Milestones, Vapendavir Antiviral Results & More In this week’s Lung […] The post Respiratory Weekly News – May 9th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Respiratory Weekly News – May 9th 2025 #News #ChronicBronchitis #nucala #vapendavir Comment below!

GSK sets up Nucala and Dupixent showdown in COPD GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD if it gets approved by the FDA.

NEWS: New study results with #GSK's anti-IL-5 antibody #Nucala in chronic obstructive pulmonary disease (#COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.

Nucala Patient Tips: 7 things you should know Easy-to-read patient tips for Nucala covering how it works, benefits, risks, and best practices.

#Nucala is used to treat severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, and chronic rhinosinusitis with nasal polyps. Common side effects include a headache and injection site reactions.